Medivir invites to a conference call on new clinical data and further studies with MIV-818 |
| September 16, 2021 | September 2021 Bond Updates |
|
STOCKHOLM, Sept. 16, 2021 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) invites to a conference call on the supporting clinical data from the completed dose escalation section of the phase 1b study with MIV-818, presented today at the European Society for Medical Oncology (ESMO)... |
| View more at: https://www.prnewswire.com:443/news-releases/medivir-invites-to-a-conference-call-on-new-clinical-data-and-further-studies-with-miv-818-301378359.html |
| Related News |
|